Ciphergen Patent Licensing Spat Sent To Arbitration

Law360, New York (July 12, 2010, 3:57 PM EDT) -- A California appeals court has ordered Molecular Analytical Systems Inc. to arbitrate its contract and fraud claims against Ciphergen Biosystems Inc. and Bio-Rad Laboratories Inc. pursuant to a licensing and settlement agreement in an earlier patent infringement dispute over laser technology.

A three-judge panel in the Sixth Appellate District of the California Court of Appeal on Friday reversed a lower court's denial of a bid by Ciphergen and Bio-Rad to compel arbitration, ruling that Molecular's claims alleging breach of a settlement agreement between it and Ciphergen...
To view the full article, register now.